Related Experiment Videos
Susceptibility markers in colorectal cancer
J Burn1, P D Chapman, D T Bishop
1School of Biochemistry and Genetics, University of Newcastle, Newcastle upon Tyne, UK.
IARC Scientific Publications
|February 28, 2001
Summary
Genetic factors significantly increase colorectal cancer risk, with inherited gene mutations contributing to a quarter of cases. Identifying these genetic susceptibilities can personalize screening and prevention strategies.
Area of Science:
- Genetics
- Oncology
- Cancer Epidemiology
Background:
- Colorectal cancer (CRC) risk is influenced by various factors including family history, age, and sex.
- Approximately 75% of CRC cases arise from somatic mutations, while inherited genetic factors account for the remainder.
- Known high-penetrance genes and numerous low-penetrance genes contribute to CRC predisposition.
Purpose of the Study:
- To review the known and potential genetic susceptibility factors for colorectal cancer.
- To discuss the complexity of gene interactions and environmental influences on CRC risk.
- To explore the implications of identifying genetic susceptibility for CRC screening and prevention.
Main Methods:
- Literature review of genetic factors in colorectal cancer.
- Analysis of the contribution of inherited versus somatic mutations.
- Discussion of major genetic syndromes associated with CRC, including familial adenomatous polyposis and Lynch syndrome.
Main Results:
- Family history, male sex, and increasing age are established risk factors for CRC.
- Inherited genetic predispositions, including high- and low-penetrance genes, contribute to about 25% of CRC cases.
- Familial adenomatous polyposis (APC gene) and Lynch syndrome (mismatch repair genes) are key examples of dominant genetic syndromes.
Conclusions:
- Genetic susceptibility testing for colorectal cancer is becoming feasible, enabling targeted screening and preventive measures.
- Understanding genetic contributions is complex due to gene-gene and gene-environment interactions.
- Potential societal and personal challenges, such as genetic discrimination, must be addressed alongside the benefits of genetic risk identification.